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Primo vessels were observed inside the lymph vessels near the caudal vena cava of
a rabbit and a rat and in the thoracic lymph duct of a mouse. In the current work we
found a primo vessel inside the lymph vessel that came out from the tumor tissue of
a mouse. A cancer model of a nude mouse was made with human lung cancer cell line
NCI-H460. We injected fluorescent nanoparticles into the xenografted tumor tissue and
studied their flow in blood, lymph, and primo vessels. Fluorescent nanoparticles flowed
through the blood vessels quickly in few minutes, and but slowly in the lymph vessels.
The bright fluorescent signals of nanoparticles disappeared within one hour in the blood
vessels but remained much longer up to several hours in the case of lymph vessels. We
found an exceptional case of lymph vessels that remained bright with fluorescence up
to 24 hours. After detailed examination we found that the bright fluorescence was due
to a putative primo vessel inside the lymph vessel. This rare observation is consistent with
Bong-Han Kim’s claim on the presence of a primo vascular system in lymph vessels. It
provides a significant suggestion on the cancer metastasis through primo vessels and
lymph vessels.Research Center, Advanced Institutes of Convergence Technology, Seoul National University, 864-1,
Gyeonggi-do, 443-270, Republic of Korea.
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The role of primo vascular system (PVS) as an additional
metastatic path of cancer cells besides well-known blood
vascular and lymphatic paths was observed [1] after the
discovery of the PVS around cancer issues which were
induced in nude mice by xenografts of human lung cancer
cell line NCI-H460 [2,3]. Further observations of the cancer-
PVS were reported with melanoma in female nude mice [4],
male C57BL6 mice [5], GFP-expressing transgenic mice [6],
and female Swiss Webster mice [7].
In this work we report another observation of a primo
vessel that came out of a cancer tissue in a nude mouse. It
was a very rare case that the primo vessel ran afloat inside
a lymph vessel emerging from the cancer tissue. Several
years ago there were reports that PVS was observed as
a floating threadlike structure inside lymph vessels of
rabbits [8,9], and rats [10e12] as well as the original
discovery by Bong-Han Kim [13]. Therefore, it is not
surprising that a primo vessel was detected in the lymph
vessel. Nevertheless, there are significant points to be
noted in the current work.
First of all, it was the first observation of the primo
vessel that came out of the cancer tissue whereas the
previous observations [2e5] were the PVS lying outside the
surrounding membrane of the cancer tissue, and therefore
it was not clear whether they were directly connected to
the cancer tissue. In the previous cases [1e7] the PVS was
physically separated from and independent of blood or
lymph vessels. In an exceptional case of green fluorescent
protein (GFP)-expressing mouse, a primo vessel came out of
a blood vessel inside a tumor tissue [6].
Second, the presence of the primo vessel inside the
lymph vessel emerging from the cancer tissue raises the
role of the PVS as a mediator of metastasis even in lymph
vessels. If the PVS somehow facilitates the migration of
cancer cells this particular kind of lymph vessel with PVS
inside could become a main path of metastasis.
Finally the observation technique was particularly
interesting. After injecting fluorescent nanoparticles into
a cancer tissue we observed the fluorescence images of
nanoparticles flowing in the blood and lymph vessels that
emanated from the cancer tissue. The flow of nanoparticles
in blood vessels were fast and disappeared in a few
minutes, while the flow in lymph vessels was relatively slow
and lasted for up to 24 hours. In 24 hours there was no
detectable fluorescence of nanoparticles in the lymph
vessels. Surprisingly there was one lymph vessel, which
remained bright with fluorescence even after 24 hours. It
turned out that the bright fluorescence was due to nano-
particles in the fibrous extracellular matrices of the primo
vessel in the lymph vessel. Thus, flowing time characteris-
tics alone can differentiate blood, lymph, or primo vessel.
2. Materials and methods
2.1. Culture of human lung cancer cells
The cell line NCI-H460 was obtained from the Korean Cell
Line Bank. Human lung cancer cells were cultured in an
RPMI-1640 medium supplemented with 1% penicillin-Carlsbad, California, USA). Cells were incubated at 37 C in
a humidified atmosphere containing 5% CO2.
2.2. Animals and cancer model
Female athymic nude mice (aged 5 weeks old, weighing
15e20 g, Charles River Laboratories) were used in accor-
dance with institutional guidelines under approved proto-
cols. For subcutaneous xenografts of human cancer,
animals were anesthetized with intraperitoneal (i.p.)
Zoletil (Verbac, Carros, France)/Rompun (Bayer, Leverku-
sen, Germany) and subcutaneously inoculated with
2 106 cells (in 0.2 mL RPMI-1640 medium).
2.3. Fluorescent nanoparticles
Cobalt-ferrite magnetic nanoparticles embedded in amor-
phous silica shells were synthesized. The shell contained
a fluorescent dye, rhodamine B isothiocyanate (orange l
max Z 555 nm), in the middle and a biocompatible poly-
ethylene glycol on the outside. The average core size of the
fluorescent magnetic nanoparticles was 9 nm, while the
average size of the enclosing shell was 50 nm [14]. The
suspension was composed of fluorescent magnetic namo-
particles and  99.9 % ethyl alcohol in a ratio 1:1.
2.4. In vivo visualization of blood, lymph, and
primo vessels
Three to four weeks after inoculation, the mice were
anesthetized with Zoletil/Rompun intraperitoneally. The
0.2 ml of fluorescent nanopartcles was directly injected
into cancer tissue with syringe. Immediately after injec-
tion, fluorescence images of fluorescent nanopartcles
flowed in lymph and primo vessels were taken by fluores-
cence stereomicroscope (MVX10, Olympus, Tokyo, Japan)
and monochrome CCD camera (DP30BW, Olympus, Tokyo,
Japan) without any surgery. Fluorescence images of blood
vessels were taken after incising the small area of skin
around cancer tissue.
2.5. Histological analysis
Samples were fixed in 10% neutral buffered formalin and
embedded in paraffin using routine procedures. Transverse
sections of 5 mm thickness were cut with a microtome,
stained with hematoxylin and eosin (H&E), and the samples
observed and photographed under a light microscope
(BX51, Olympus, Japan) and CCD camera (Infinity 2,
Lumenera, Ottawa, Canada).
3. Results
Fortuitously, we were able to find the primo vessel in
a lymph vessel that accompanied a blood vessel, which
came out of the tumor tissue as shown in Fig. 1. Nano-
particles flowed away in the blood vessel very fast. Within
several minutes after injection of nanopartcles into the
tumor tissue the blood vessel returned to its normal
Figure 1 (A) Ventral view of the mouse with a xenografted tumor tissue (Figure taken from outside of the skin). The bright part is
the tumor tissue (arrow) and the bright curve is the lymph vessel (double arrows). The brightness is due to the fluorescence signal
of nanoparticles injected into the tumor tissue. Black rectangular region was studied after turning over the skin to observe the area
from the abdominal wall side in panel (B); (B) fluorescence signal of nanoparticles flowed through the lymph vessel (arrows) along
the blood vessel (dark wide curve). Image was obtained after incision and turning over the skin to expose the inner side of the skin.
The bright curve inside the lymph vessel (solid arrows) was taken after 24 hours from injection of nanopartiles.
208 S. Lee et al.appearance (dark in fluorescence view). The lymph vessel
kept the flow of nanoparticles much longer up to 24 hours.
After 24 hours the lymph did not show the fluorescence of
nanoparticles because they flowed away. After turning over
the skin and observing from the abdominal side we found
and an apparent lymph vessel remained bright in fluores-
cence even after 24 hours. It was a rare case (Fig. 1B).
The H&E image of the cross section of the blood and
accompanying lymph vessel showed indeed a thin thread-
like primo vessel bearing nanoparticles. Apparently they
flowed in the primo vessel whose diameter was about
20 mm, and had one nucleus, and fibrous materials in the
vessel (Fig. 2). The nanoparticles were not uniformly
distributed in the cross section of the primo vessel. They
were trapped in the fibrous extra cellular matrices of the
primo vessel. There were no nanoparticles in the lymph
vessel or on the lymph wall at all.
4. Discussion
Theflow time of the nanoparticleswas distinctively different
for the three cases of blood, lymph and primo vessels. In theFigure 2 (A) Cross section hematoxylin and eosin (H&E) image of
is located inside the lymph vessel (dotted arrows). The large blood
nanoparticles in the primo vessel (arrow) located inside the lymph v
The diameter of the primo vessel is about 20 mm as expected for ablood vessels the signals of nanoparticles remained in the
order of 10minutes,while in the lymph vessels in the order of
several hours but less than 24 hours. Only the primo vessel
showed long lasting signals beyond 24 hours.
There were many reports on the threadlike primo vessel
inside lymph vessel of rats and rabbits [8e13], and the one
in a mouse was first reported by Choi et al. [15]. The
presence of a primo vessel inside a lymph vessel emerging
from a cancer tissue in a nude mouse was observed for the
first time. Although intralymph vascular PVS was observed
in many occasions the one in connection with cancer tissue
calls for special attention. Cancer metastasis is well known
to occur through lymph flow, and in addition through
a primo vessel [1]. It is a natural conjecture that metastasis
may occur more frequently through the double route of the
combined system of primo vessel inside a lymph vessel. It
would be worth to examine whether a more vicious
metastasis has such combined routes.
It raises an open question how many of the currently
known lymphatic metastases were, in fact, the combined
path of a PVS inside a lymph vessel. The finding of this
combined system was by chance, and very rare. Nothe isolated sample shown Figure 1B. The primo vessel (arrow)
vessel is indicated with double arrow; (B) fluorescence signal of
essel. Fluorescent nanoparticles were only in the primo vessel.
primo vessel; (B) fluorescent image of (A).
Primo vessel in cancer tissue 209thorough histological analysis was performed due to lack of
samples. We do not currently know the way to observe such
an intra-lymph PVS systematically. Further investigation in
this purpose is necessary. In addition, we did not study
other types of cancer models than the xenograft one which
is worth more studies. One last remark on the limit of the
current work is that no direct proof of flow of nanoparticles
was given. It is not ruled out that nanoparticles flowed in
the lymphatic fluid and were absorbed by the primo vessel.
Further systematic studies are necessary to resolve this
criticism.
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